Showing 33–48 of 114 resultsSorted by popularity
Anastrozole (Arimidex) is a benzyltriazole-derived Type II non-steroidal aromatase inhibitor that competitively binds the heme group of CYP19A1, blocking androgen-to-estrogen conversion. A reversible, high-fidelity tool for precise estrogen modulation research.
Masteron (Drostanolone Enanthate) is a DHT derivative featuring a 2-methyl group for metabolic stability and an enanthate ester for a 7-10 day half-life. It delivers pure androgenic signaling without aromatization while exhibiting mild anti-estrogenic properties.
Blend-300 is a sophisticated multi-compound injectable formulation combining Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate for cooperative androgen receptor saturation. It provides both immediate and sustained anabolic signaling across multiple steroidal pathways.
Superdrol (Methasterone) is a highly potent C17-alpha-alkylated DHT derivative featuring a 2-alpha methyl group that prevents aromatization while maximizing anabolic potency. It delivers exceptional myofibrillar protein transcription with no estrogenic conversion.
Primobolan (Methenolone Enanthate) 200mg/ml is a high-concentration injectable DHT derivative with a 1-methyl substitution that prevents aromatization while preserving clean anabolic signaling. The enanthate ester provides sustained release for tissue preservation research.
Sustanon 250 is a multi-ester testosterone blend (Propionate, Phenylpropionate, Isocaproate, Decanoate) engineered for a bimodal pharmacokinetic profile with a 15-18 day terminal half-life. It provides both immediate receptor saturation and prolonged steady-state androgen levels.
Semaglutide is a long-acting GLP-1 receptor agonist with a 168-hour half-life that stimulates glucose-dependent insulin secretion and centrally suppresses appetite. An oral formulation for investigating sustained incretin-mediated weight loss.
Stanolone (DHT) is the pure 5-alpha-reduced androgen that binds the nuclear androgen receptor with 3-10 times higher affinity than testosterone. It is structurally incapable of aromatization, providing pure androgenic signaling for research into DHT-specific pathways.
19-nor androgen for progestin activity and collagen research. Study joint recovery and anabolic pathways.
Finasteride is a selective Type II 5-alpha-reductase inhibitor that competitively blocks testosterone-to-DHT conversion, reducing serum DHT by approximately 70%. A targeted research tool for investigating androgen-dependent hair follicle preservation.
Dianabol (Methandienone) is a potent C17-alpha-alkylated testosterone derivative featuring a delta-1 double bond for enhanced anabolic activity. It drives rapid myofibrillar protein synthesis and positive nitrogen balance, rendering it a core oral androgen for muscle growth research.
Supertest 450 is an ultra-high-concentration multi-ester testosterone blend at 450mg/ml combining Enanthate, Cypionate, and Decanoate esters. Staggered ester cleavage provides both rapid onset and extended sustained release for maximal androgenic synergy.
Winstrol (Stanozolol) 100mg/ml Injectable is a high-concentration pyrazole-modified DHT derivative that inhibits SHBG synthesis and binds microsomal androgen receptors. The oil-based delivery provides a 24-hour half-life with superior bioavailability.
BLEND-500 TRE DE Live Blend Oil Steroids Injectable for research use.
SLU-PP-332 is a first-in-class pan-agonist of Estrogen-Related Receptors (alpha, beta, gamma) that recruits PGC-1alpha to upregulate mitochondrial oxidative phosphorylation. An oral exercise mimetic for investigating metabolic adaptation without physical exertion.
GW-501516 (Cardarine) is a high-affinity PPAR-delta agonist that recruits PGC-1alpha co-activators to upregulate fatty acid oxidation, mitochondrial biogenesis, and Type I oxidative fiber conversion. An excellent endurance-enhancing research compound.
End of content
End of content
No products in the cart.
